![[The Fix] Accelerating Healthtech](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,quality=80,format=auto,width=720,onerror=redirect/uploads/asset/file/4e692593-e308-4dbb-b6d4-7802e34f2d69/T_personal_shared_-_Frame_543.jpg?t=1787143792)
Welcome to another exciting week from the Healthcare and Life Sciences ecosystem! We've got a packed newsletter full of insights, events, and inspiring stories from the heart of innovation.
Table of Contents
🖼️ Accelerating Healthtech
️News:
🧬 Biotech
🌏 IASO Biotechnology Acquires Singapore-Based MediSix Therapeutics: China's IASO Bio completed its acquisition of MediSix Therapeutics, integrating its novel protein expression blocker (PEBL) T-cell engineering platform to prevent fratricide in CAR-T cell therapies.
🧬 Biogen Finalizes Acquisition of RayThera to Boost Immunology Pipeline: Biogen completed its takeover of RayThera Inc., absorbing a suite of small-molecule immunology assets with lead candidates entering Phase 1 clinical development.
💊 Roche’s Oral Factor B Inhibitor Shows Strong Efficacy in Kidney Trials: Roche published positive Phase 2 clinical data for its oral complement alternative pathway inhibitor, demonstrating significant proteinuria reduction in patients with IgA nephropathy.
🧠 Denali Therapeutics Advances Transport Vehicle Platform for Brain Delivery: Denali released positive interim safety metrics for its enzyme replacement therapy utilizing its proprietary BBB-crossing transport vehicle technology.
🩸 Agios Pharmaceuticals Finalizes Pivotal Phase 3 Trial Enrollment in Thalassemia: Agios completed patient recruitment for its Phase 3 study evaluating mitapivat in non-transfusion-dependent alpha- and beta-thalassemia.
💻 Digital Health
🤖 OpenAI Launches ChatGPT Health Module for Personal Medical Guidance: OpenAI officially rolled out its dedicated ChatGPT Health experience across U.S. users, establishing a tailored, HIPAA-compliant interface for personalized health queries and health system navigation.
💉 Digital Health Capital Shifts into GLP-1 Companion Ecosystems: Market intelligence reports highlighted a major strategic pivot as healthtech venture funding moves away from direct-to-consumer prescribing storefronts toward post-prescription adherence and lifestyle companion software.
📱 Samsung Health Expands Integrated Continuous Care Hub with Enterprise Partners: Samsung Health launched broader API integrations connecting real-time consumer wearable sensor data directly with clinical decision platforms used by major health networks.
🏥 Mayo Clinic and Epic Partner to Deploy Predictive Sepsis Workflow AI: Mayo Clinic integrated a new co-developed AI risk-stratification tool into its EHR infrastructure to detect subtle systemic patient deterioration prior to septic shock onset.
📊 Rethink Health Report Outlines Acceleration of Ambient AI Documentation: Industry metrics showed that over 35% of U.S. outpatient practices have adopted ambient voice AI scribes into daily clinical encounters to reduce administrative burden.
⚖️ Regulatory Affairs
🩸 FDA Grants Accelerated Approval to BMS's Iberdomide for Multiple Myeloma: The FDA approved Bristol-Myers Squibb’s Zenbexus (iberdomide) in combination with daratumumab and dexamethasone for adults with relapsed or refractory multiple myeloma.
🧪 FDA Compounding Advisory Panel Recommends Greenlight for Key Peptides: An FDA advisory committee voted in favor of adding six high-demand investigational peptides to the bulks list for specialized pharmacy compounding.
🧬 FDA Grants Fast Track Designation to Novel mRNA Rare Disease Therapeutic: Regulators accelerated the review pathway for an investigational lipid nanoparticle-formulated mRNA therapy targeting severe glycogen storage diseases.
⚠️ FDA Issues Class I Risk Warning for Massive National Egg Recall: The FDA elevated a widespread multi-state salmonella outbreak recall involving 1.6 million dozen eggs to its highest urgency level following 26 hospitalizations.
🩺 UK’s MHRA Approves Streamlined Clinical Trial Framework for MedTech: The UK regulatory body implemented a novel pilot pathway aimed at reducing approval timelines for early-stage software and digital diagnostic medical devices.FDA Proposes Major Rule Overhaul to Modernize Global Drug Manufacturing Registrations: Federal regulators introduced a sweeping framework intended to digitize, clean, and aggressively enforce automated reporting standards for both domestic and foreign commercial pharmaceutical manufacturing facilities
🛒 Funding roundup:
Company / Partnership | Funding Amount | Focus Area | Location | Investors / Partners |
Vaderis Therapeutics | $152.0M (Series B) | Rare disease & hereditary hemorrhagic telangiectasia therapies | Basel, Switzerland | Goldman Sachs Alternatives & TCGX (Co-leads) |
Epicrispr Biotechnology | $90.0M (Series B) | Epigenetic silencing & rare disease gene therapy | San Francisco, US | Institutional biopharma syndicate, Sanofi Ventures |
InduPro Therapeutics | $77.0M (Series B) | Proximity labeling & bispecific ADC oncology therapeutics | Seattle, US | The Column Group (Lead), Vida Ventures, MRL Ventures Fund, Sanofi, Eli Lilly |
Infinimmune | $75.0M (Series A) | Human-derived antibody therapeutics & immunology | Alameda, US | Regeneron Ventures & Playground Global (Co-leads), RA Capital Management, Merck Global Health Innovation Fund |
Boulevard Bio | $65.0M (Launch) | B-cell driven autoimmune disease therapeutics | United States | Deerfield Management |
Beyang Therapeutics | $30.0M (Series A) | AI-driven drug discovery & ophthalmic therapeutics | Chengdu, China | Legend Capital & Shanghai Healthcare Capital (Co-leads), CMS, Harbor & Canton Capital |
Remedium Bio | $10.0M (Series A) | Gene therapy platform for obesity & metabolic disease | Boston, US | Lifespan Vision Ventures (Lead), Eli Lilly and Company, HKX Capital |
MHRA UK delivers a substantive win for HealthTech
🚀 The Medicines and Healthcare products Regulatory Agency is paving a fast track for digital health innovation.
For the longest time, Software as a Medical Device (SaMD) developers faced traditional regulatory frameworks that treated fast-iterating software like slow-moving pharmaceuticals.
Hopefully no more! The MHRA’s newly launched streamlined clinical trial frameworks and risk-proportionate pilot pathways are set to position the UK as a global launchpad for digital diagnostics and medical AI.
Instead of months of administrative delay for minor software updates, early-stage developers can now leverage expedited trial reviews and Predetermined Change Control Plans (PCCPs). These allow algorithms to adapt, improve, and deploy safely in frontline clinical settings.
Here is why this is great:
💡 Speed to Market: Cutting pre-market trial friction brings cutting-edge digital diagnostics to NHS patients significantly faster, improving early detection and clinical outcomes.
🔄 Iterative Innovation: Software updates and AI refinements no longer mean starting the regulatory clock from scratch. Developers can continuously optimize tools based on real-world clinical feedback.
🎯 Parallel HTA Alignment: Streamlining regulatory trials alongside bodies like NICE means startups build their clinical safety and NHS adoption evidence simultaneously.
🌐 Global Competitiveness: A agile, risk-proportionate regulatory corridor makes the UK an incredibly attractive hub for international digital health investment and clinical testing.
Regulatory evolution shouldn't slow down innovation instead, it should guide it safely to market. 👏
🏢Job Opportunities
Listed chronological order (latest at the end!).
When you apply tell the company you heard about the role @ The Fix! (Click for link to listing)
💡Partner Manager, Global Health, Anthropic (US)
💡Expert Opportunity - Medical Science Liaison / Medical Affairs Professional, Ethos (SG)
💡Senior Product Designer, 9amHealth (US)
💡Director of Product, Oula (US)
💡Chief Product Officer, Viz.ai (US)
💡Solutions Lead, Healthcare, Protege (Remote)
💡Senior Product Manager, Sleep, WHOOP (US)
💡Director of Product Design, Runna (UK)
💡Senior Advisor (Core), Health Innovation East (UK)
💡Regulatory Affairs Lead, B1Neuro (SG)
💡Senior, Demand Generation and Account-Based Marketing, Amplify Health (SG)
💡Clinical Safety Officer, Healthtech-1 (UK)
💡Medical Director, Clinical Product, Counterpart Health Clover Health (US)
💡Clinical Director, Heidi (US remote)
💡VP of Clinical Services and Executive Medical Director, Solace Solace (US)
💡Content Writer, The Doctor's Kitchen The Doctor’s Kitchen (UK)
💡Clinical Engagement Specialist, Patchwork Health (UK)
💡Clinical Lead, Accurx (UK)
💡Clinical Safety Officer Doccla (UK)
💡Senior Director, Clinical Quality, Omada health (US)
💡Head of Clinical AI, Sanome (UK)
💡Senior Product Manager, Blue Health Intelligence (Netherlands)
💡Principal Software Engineer, Phlo (UK)
💡Senior Program Officer/Program Officer Path (india, Indonesia)
💡VP, Commercial, 52 North (UK)
💡Clinical Product Lead, C the Signs (UK)
💡 Health Economics & Market Access Senior Manager / Deputy - SEA and Phamaging Countries, AEIRA (SG)
💡 QA Senior Manager, AEIRA (SG)
💡 Commercial Excellent Deputy, AEIRA (SG)
💡 Quality Officer, HeliosX (UK)
💡 Product Manager - Patient Experience, Conduit Health (US)
💡 Director, Product Management, Hinge Health (US)
💡 Senior Product Manager - Payments, Flo Health (UK)
💡 Sr. Product Manager, Karoo Health (US)
💡 Clinical Lead - New Products, Eucalyptus (UK)
💡 Medical Director - Nourish Medical, Nourish (US)
💡 Lead Director, Clinical and Digital Health Programs, CVS Health (US)
💡 Clinical Advisor, Voy (UK)
💡 North America Sales Lead, Vira Health (Canada)
💡 Head of Partnerships, 01Health (UK)
💡 Product Manager, Health and Home Infrastructure, Google (UK)
💡 Associate, Prova Health (UK)
💡 AI Implementation Manager, Cambridge University Hospitals NHS Foundation Trust (UK)
🌆Upcoming Events
🍵Upcoming Tech Brews meetings
Edinburgh - Aug 20, 5:00PM “Networking”
Sri Lanka – Sat 22 Aug, 9:30AM "Japan Health/Bio Coffee Club Speaker: Rachel Lin"
Japan – Sat 22 Aug, 9:00AM "Japan Health/Bio Coffee Club Speaker: Rachel Lin"
Singapore – Sat 22 Aug, 9:00AM "Sat Health & Bio Brews SG (AMA)"
Mumbai– Sat 22 Aug, 9:00AM "Health & Bio Brews Mumbai Speaker: Aditya Daftary"
Singapore – Sat 29 Aug, 9:00AM "Sat Health & Bio Brews SG Speaker: "
Japan – Sat 29 Aug, 9:00AM "Japan Health/Bio Coffee Club Speaker: Wanping AW"
🌏 Global MedTech & Health Summits
August 20, 2026: Medical Fair China China Medical Fair China 2026 explores the next generation of medical technology, showcasing advances in AI, digital healthcare, surgical robotics, minimally invasive technologies, and global medtech innovation. The event brings together industry leaders, researchers, and clinicians to accelerate the translation of innovation into clinical practice and international growth. https://www.medicalfair.cn/en/about.html
August 21–23, 2026: India Health 2026 India Large-scale healthcare exhibition connecting global medical technology companies, healthcare providers, and industry leaders with India's rapidly growing healthcare ecosystem.
August 23-25, 2026: HIMMS APAC Singapore HIMSS26 APAC brings together healthcare leaders, government voices, clinicians, innovators, and technology partners from across the region to explore how health systems can move from AI ambition to evidence-based action. https://www.himss.org/events-overview/apac-conference-and-exhibition/overview
September 1, 2026: Asia Bio Partnering Forum Singapore The premier Asia-Pacific biopharma partnering conference, bringing together global life sciences leaders to foster cross-border collaborations, investment, licensing, and strategic partnerships across the region. https://informaconnect.com/asia-bio-partnering-forum/?gad_source=1&gad_campaignid=23883457671&gbraid=0AAAAADLlp5RLu1gQgINZIHnvee4k_pviB&gclid=CjwKCAjwuanRBhBSEiwAY5y6V0dyrzaeWq9ZplmvdAzO4b964WqOdnGbmBvWLTaxuDLK7P7AdnwokhoCxzoQAvD_BwE
September 14–16, 2026: WHX Dubai Tech Dubai, UAE One of the Middle East's largest healthcare technology exhibitions, showcasing innovations in digital health, medical devices, diagnostics, and healthcare infrastructure while connecting global healthcare leaders and innovators. https://www.worldhealthexpo.com/events/healthcare/dubai/en/home.html
September 14–17, 2026: Becker's Health IT + Digital Health + Revenue Cycle Management Conference Boston, USA Leading conference for healthcare executives focused on AI, digital transformation, interoperability, cybersecurity, revenue cycle management, and technology strategies that improve healthcare delivery and operational performance. https://conferences.beckershospitalreview.com/HIT_RCM_2026
September 16–17, 2026: LSX World Congress USA Boston, USA Premier life sciences partnering event bringing together biotech, medtech, pharmatech, investors, and pharmaceutical leaders to showcase innovation, build strategic partnerships, and shape the future of healthcare. https://informaconnect.com/lsx-world-congress-usa/
September 22–23, 2026: World Medical Innovation Forum Boston, USA Global forum convening healthcare leaders, innovators, researchers, investors, and policymakers to explore emerging opportunities, technologies, and challenges shaping the future of medical innovation.
Get your event listed here! Simply fill in the form here
Editorial: Terence Tan
Events & Opportunities: Eugene Fang
Disclaimers- Views, thoughts, and opinions expressed in the text belong solely to the author, and not necessarily to the author's employer, organization, committee or other group or individual. The above analysis is also purely personal opinion and should not be taken as professional advice. All content intended for informational purposes.
Disclosures- At the time of this post, The Fix or the team have not received any sponsorship, whether financial or in-kind for this post. There is no equity or financial stake in any of the private companies mentioned above
